Company Name
Zhejiang Tiantai Pharmaceutical Co.,Ltd.
Year of Establishment
1998
Annual Turnover(USD)
500,000 to 99,999,999
Company Introduction
Zhejiang Tiantai Pharmaceutical Co., Ltd. (listed), founded in June 1998, is specialized in R&D, manufacturing and sales of antifungal and antibiotics series featured APIs products including Clindamycin Hydrochloride, Clindamycin Phosphate and Amphotericin B, and the CRO&CDMO business of APIs. The company is one of the major manufacturers of Clindamycin Hydrochloride and Clindamycin Phosphate at home and abroad.
Focusing on the big health industry, the company has built the traditional featured APIs and API CDMO&CRO business plate and synthetic biology drugs plate. Relying on the advantages of existing products, technologies, teams and platforms, the company become a low-cost, scaled, APIs-and-preparations integrated manufacturing base of featured generic drugs, and gradually developed towards the innovative drugs.
Main Competitive Advantages
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service,
Website
http://www.ttpharm.com
Other Competitive Advantages
Prompt delivery & stable supply chain.
Patents and Copyright
brand of "ttpharm"
Milestone
April 2021 Started to build Cangshan Plant
August 2020 Takeover 100% shares of Hangzhou Lead Biotech Co., Ltd.
March 2018 Wholly-owned subsidiary Hangzhou Tianze Bio-Pharmaceutical Co., Ltd. was established
November 2017 Listed as an enterprise to be listed by Financial Office of Tiantai County People's Government
November 2000 Company name changed to be Zhejiang Tiantai Pharmaceutical Co., Ltd.
June 1998 Zhejiang Shengchang Pharmaceitucal Co., Ltd. was established